Reviewing Addus HomeCare (NASDAQ:ADUS) & Joint (NASDAQ:JYNT)

Addus HomeCare (NASDAQ:ADUS) and Joint (NASDAQ:JYNT) are both healthcare companies, but which is the superior business? We will contrast the two businesses based on the strength of their valuation, profitability, institutional ownership, earnings, dividends, risk and analyst recommendations.

Valuation and Earnings

This table compares Addus HomeCare and Joint”s gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Addus HomeCare	$1.42 billion	1.60	$95.91 million	$5.70	21.37
Joint	$54.90 million	1.85	$2.91 million	$0.27	26.67

Addus HomeCare has higher revenue and earnings than Joint. Addus HomeCare is trading at a lower price-to-earnings ratio than Joint, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares Addus HomeCare and Joint’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Addus HomeCare	7.13%	9.96%	7.62%
Joint	6.49%	12.02%	3.47%

Institutional & Insider Ownership

95.3% of Addus HomeCare shares are held by institutional investors. Comparatively, 76.9% of Joint shares are held by institutional investors. 4.1% of Addus HomeCare shares are held by company insiders. Comparatively, 30.2% of Joint shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Risk & Volatility

Addus HomeCare has a beta of 0.83, suggesting that its stock price is 17% less volatile than the S&P 500. Comparatively, Joint has a beta of 1.09, suggesting that its stock price is 9% more volatile than the S&P 500.

Analyst Recommendations

This is a breakdown of recent recommendations and price targets for Addus HomeCare and Joint, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Addus HomeCare	1	4	5	1	2.55
Joint	1	2	0	0	1.67

Addus HomeCare currently has a consensus price target of $129.33, indicating a potential upside of 6.18%. Given Addus HomeCare’s stronger consensus rating and higher probable upside, analysts plainly believe Addus HomeCare is more favorable than Joint.

Summary

Addus HomeCare beats Joint on 10 of the 15 factors compared between the two stocks.

About Addus HomeCare

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health. The Personal Care segment provides non-medical assistance with activities of daily living. This segment offers services that include assistance with bathing, grooming, oral care, feeding and dressing, medication reminders, meal planning and preparation, housekeeping, and transportation services. The Hospice segment provides palliative nursing care, social work, spiritual counseling, homemaker, and bereavement counseling services for people who are terminally ill, as well as related services for their families. The Home Health segment offers skilled nursing and physical, occupational, and speech therapy for the individuals who requires assistance during an illness or after hospitalization. The company's payor clients include federal, state, and local governmental agencies; managed care organizations; commercial insurers; and private individuals. Addus HomeCare Corporation was founded in 1979 and is headquartered in Frisco, Texas.

About Joint

The Joint Corp. operates and franchises chiropractic clinics in the United States. The company operates in two segments, Corporate Clinics and Franchise Operations. The Joint Corp. was incorporated in 2010 and is headquartered in Scottsdale, Arizona.